Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Whitfield

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|March 8, 2007
Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistanceRobert C Noland, John P Thyfault, Sarah T Henes, et al.
Cancer|May 17, 2014
Diet and proinflammatory cytokine levels in head and neck squamous cell carcinomaAnna E Arthur, Karen E Peterson, Jincheng Shen, et al.
Genes & Development|April 6, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Genes & Development|September 2, 2025
Corrigendum: Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Life Science Alliance|March 3, 2021
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic isletsMariano F Zacarías-Fluck, Toni Jauset, Sandra Martínez-Martín, et al.
Nature Communications|August 19, 2014
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosisDaniela Annibali, Jonathan R Whitfield, Emilia Favuzzi, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
Cancer Research Communications|March 2, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and SeedingDaniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, et al.
Science Translational Medicine|March 22, 2019
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapyMarie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
American Journal of Physiology. Endocrinology and Metabolism|March 8, 2007
Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistanceRobert C Noland, John P Thyfault, Sarah T Henes, et al.
Cancer|May 17, 2014
Diet and proinflammatory cytokine levels in head and neck squamous cell carcinomaAnna E Arthur, Karen E Peterson, Jincheng Shen, et al.
Genes & Development|April 6, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Genes & Development|September 2, 2025
Corrigendum: Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Life Science Alliance|March 3, 2021
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic isletsMariano F Zacarías-Fluck, Toni Jauset, Sandra Martínez-Martín, et al.
Nature Communications|August 19, 2014
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosisDaniela Annibali, Jonathan R Whitfield, Emilia Favuzzi, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
Cancer Research Communications|March 2, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and SeedingDaniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, et al.
Science Translational Medicine|March 22, 2019
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapyMarie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, et al.
Pageof 17